Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pateman

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Medicinal Chemistry|May 17, 2003
The design of potent, non-peptidic inhibitors of hepatitis C proteaseDavid M Andrews, Helene M Chaignot, Barry A Coomber, et al.
Organic Letters|November 25, 2003
Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic optimization of inhibitors of hepatitis C virus NS3/4A proteaseDavid M Andrews, Michael C Barnes, Mike D Dowle, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2007
Selective and dual action orally active inhibitors of thrombin and factor XaRobert J Young, David Brown, Cynthia L Burns-Kurtis, et al.
Journal of Cardiovascular Pharmacology|July 23, 2008
Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitorMelanie A Abboud, Saul J Needle, Cynthia L Burns-Kurtis, et al.
Journal of Medicinal Chemistry|March 7, 2007
Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamidesChuen Chan, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2006
Structure- and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifsRobert J Young, Matthew Campbell, Alan D Borthwick, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifsRobert J Young, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifsNigel S Watson, Carl Adams, David Belton, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifsRobert J Young, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifsRobert J Young, Carl Adams, Mike Blows, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Medicinal Chemistry|May 17, 2003
The design of potent, non-peptidic inhibitors of hepatitis C proteaseDavid M Andrews, Helene M Chaignot, Barry A Coomber, et al.
Organic Letters|November 25, 2003
Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic optimization of inhibitors of hepatitis C virus NS3/4A proteaseDavid M Andrews, Michael C Barnes, Mike D Dowle, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2007
Selective and dual action orally active inhibitors of thrombin and factor XaRobert J Young, David Brown, Cynthia L Burns-Kurtis, et al.
Journal of Cardiovascular Pharmacology|July 23, 2008
Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitorMelanie A Abboud, Saul J Needle, Cynthia L Burns-Kurtis, et al.
Journal of Medicinal Chemistry|March 7, 2007
Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamidesChuen Chan, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2006
Structure- and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifsRobert J Young, Matthew Campbell, Alan D Borthwick, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifsRobert J Young, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifsNigel S Watson, Carl Adams, David Belton, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifsRobert J Young, Alan D Borthwick, David Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifsRobert J Young, Carl Adams, Mike Blows, et al.
Pageof 3